Table 3.
Clinical and Research Applications across Important Genome-Editing Techniques
| Serial No. | Parameter | ZFN | TALEN | CRISPER/Cas | Reference |
|---|---|---|---|---|---|
| 1 | diagnostic utility | + | + | +++ | 60 |
| 2 | clinical trial use | ++ | + | +++ | 61 |
| 3 | utility as epigenetic marker | ++ | +++ | ++++ | 62 |
| 4 | making gene-knockout models for research | no | no | yes (CRISPRi) | 63 |
| 5 | capacity for modification of mitochondrial DNA | no | no | probable | 64 |
| 6 | genetic editing in human babies | no | no | yes | 65 |
| 7 | RNA editing | no | no | yes | 66 |